MAPT and Alzheimer disease: The study by Zhang Q et al. found that CPPs could activate PP2A to prevent AD-like tau protein hyperphosphorylation, which could rescue neuronal loss and alleviate AD-like cognitive impairment (Zhang et al., 2018).